Neurocrine Biosciences, Inc. (NBIX)
131.78
+0.11
(+0.08%)
USD |
NASDAQ |
May 01, 16:00
131.79
+0.01
(+0.01%)
After-Hours: 20:00
Neurocrine Biosciences EPS Diluted (Quarterly) : 1.482 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Soleno Therapeutics, Inc. | 0.7904 |
| Glaukos Corp. | -0.341 |
| Edgewise Therapeutics, Inc. | -0.4737 |
| Nuvalent, Inc. | -1.585 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 153.70M |
| Revenue (Quarterly) | 805.50M |
| Total Expenses (Quarterly) | 651.80M |
| Enterprise Value | 12.22B |
| Gross Profit Margin (Quarterly) | 97.82% |
| Profit Margin (Quarterly) | 19.08% |
| Earnings Yield | 3.54% |
| Operating Earnings Yield | 4.72% |
| Normalized Earnings Yield | 3.652 |